Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort Study
about
Integrated therapy for HIV and cryptococcosisHIV-Associated Cryptococcal Meningitis: Bridging the Gap Between Developed and Resource-Limited SettingsPreheating of urine improves the specificity of urinary cryptococcal antigen testing using the lateral flow assay.Risk Factors for Cryptococcal Meningitis: A Single United States Center Experience.Evolution of Cryptococcal Antigen Testing: What is new?Accelerating the Uptake and Timing of Antiretroviral Therapy Initiation in Sub-Saharan Africa: An Operations Research AgendaMinimizing fungal disease deaths will allow the UNAIDS target of reducing annual AIDS deaths below 500 000 by 2020 to be realizedEstimating the cost-per-result of a national reflexed Cryptococcal antigenaemia screening program: Forecasting the impact of potential HIV guideline changes and treatment goals.The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis).High Treatment Success Rates Among HIV-Infected Multidrug-Resistant Tuberculosis Patients After Expansion of Antiretroviral Therapy in Botswana, 2006-2013.Point-of-Care Testing for Cryptococcal Disease Among Hospitalized Human Immunodeficiency Virus-Infected Adults in Ethiopia.Inadequacy of High-Dose Fluconazole Monotherapy Among Cerebrospinal Fluid Cryptococcal Antigen (CrAg)-Positive Human Immunodeficiency Virus-Infected Persons in an Ethiopian CrAg Screening Program.High Cryptococcal Antigen Titers in Blood are Predictive of Subclinical Cryptococcal Meningitis Among HIV-Infected Patients.CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis.Cryptococcal Antigen Screening in Asymptomatic HIV-Infected Antiretroviral Naïve Patients in Cameroon and Evaluation of the New Semi-Quantitative Biosynex CryptoPS Test.The war on cryptococcosis: A Review of the antifungal arsenal.Diagnostic and therapeutic strategies in cryptococcosis: impact on outcome.Cryptococcal antigen positivity combined with the percentage of HIV-seropositive samples with CD4 counts <100 cells/μl identifies districts in South Africa with advanced burden of disease.Burden of Fungal Infections in Colombia.
P2860
Q28077707-E4F8F9DF-3B14-401A-8413-FABDB20ACB1FQ28078958-4164E3BC-ABDF-41E9-A1E2-F799CDA827C4Q33663275-EBA2E588-5970-44DC-9D78-A3193E936148Q36097979-A9FF7389-3FEB-4CB2-A02A-4DCFADCBC55FQ36873953-AC7E1F4B-0119-446E-BFEA-9C4144739AE0Q37162105-74D140C1-F83F-4B64-A0C4-FCC78C959D80Q37393668-E4FDEAB2-9B9C-4693-AE86-DF37C9297F0EQ38614177-3B4C87EE-7903-442D-9412-13C0AADA1AA6Q39189670-E0FCA012-EB6C-4BF3-B5F2-9231CFBCAE64Q39463170-EEFACF42-F76C-428B-A51C-1863CED77F0CQ40092528-3612BC20-ED7E-4379-B181-DB4A50867865Q45326483-6B3E2AC2-535C-40E9-898B-A3CD76DBCE20Q46801174-4C84F3DE-2428-47EB-B1CD-E2B48EB703C7Q51365549-882CB801-FE39-43EE-9246-9DD2895B0F9FQ52624536-5600D92C-2725-401A-AB2C-011B60E40B11Q54260674-81A1510C-9696-4D34-9855-EE089409284EQ55229762-EB3A05FE-8FED-4D7A-A8E4-5826A00FB46AQ55396875-8700285F-5EE3-4CE7-B8EA-35C1EACD4F52Q55422790-DCFE7F10-1ADA-40E7-8344-1405E80ECCC4
P2860
Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort Study
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cryptococcal Antigen Screening ...... ca: A Prospective Cohort Study
@ast
Cryptococcal Antigen Screening ...... ca: A Prospective Cohort Study
@en
type
label
Cryptococcal Antigen Screening ...... ca: A Prospective Cohort Study
@ast
Cryptococcal Antigen Screening ...... ca: A Prospective Cohort Study
@en
prefLabel
Cryptococcal Antigen Screening ...... ca: A Prospective Cohort Study
@ast
Cryptococcal Antigen Screening ...... ca: A Prospective Cohort Study
@en
P2093
P2860
P50
P356
P1476
Cryptococcal Antigen Screening ...... ca: A Prospective Cohort Study
@en
P2093
Anna Cross
Joseph Nicholas Jarvis
Nelesh P Govender
Nicky Longley
Nicola Kelly
P2860
P304
P356
10.1093/CID/CIV936
P407
P577
2015-11-12T00:00:00Z